| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/05/2005 | US6913674 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 07/05/2005 | CA2119572C Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058852A1 Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines |
| 06/30/2005 | WO2005058851A1 Process for the separation of organic nitrosonium and/or hydroxylamine compounds by means of cation exchange resins and recovery and oxidation processes based thereon |
| 06/30/2005 | WO2005058850A1 Process for the separation of organic hydroxylamine and nitrosonium compounds and its use in the oxidation of hydroxy compounds |
| 06/30/2005 | WO2005058849A1 New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058269A1 Merocyanine derivatives for cosmetic use |
| 06/30/2005 | WO2005034878A3 Pyrovalerone analogs and therapeutic uses thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143394 1-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]cyclohexanol; non-hormonal therapy; thermoregulatory dysfunction, vasomotor symptoms (VMS); antidepressant, sterss rerelieving, anxiolytic agent; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome |
| 06/30/2005 | US20050143393 Bactericides; infection therapy; topical administering |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1548866A1 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 06/29/2005 | EP1548010A1 Process for producing oxycarbonyl-substituted piperazine derivative |
| 06/29/2005 | EP1546139A1 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators |
| 06/29/2005 | EP1546119A1 Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546086A2 Aminoalcohol derivatives |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1633287A Biphenil derivatives and their use as antiandrogenic agents |
| 06/29/2005 | CN1631884A Process for preparing dimethomoph |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208295C Reduction of carbonyl compounds by silane in presence of zinc catalyst |
| 06/28/2005 | US6911478 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/28/2005 | US6911477 Muscarinic receptor agonists |
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911433 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 06/28/2005 | CA2057492C Multifunctional additive for lubricating oils |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/24/2005 | CA2454453A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 06/23/2005 | WO2005056528A1 Carboxamide derivatives |
| 06/23/2005 | WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof |
| 06/23/2005 | WO2005056516A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2005033056A3 Triphenylethylene compounds as selective estrogen receptor modulators |
| 06/23/2005 | US20050137396 Process for preparing benzoic acids |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137211 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 06/23/2005 | US20050137210 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders |
| 06/23/2005 | US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | CA2549548A1 Carboxamide derivatives |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1542966A1 Aromatic liver x-receptor modulators |
| 06/22/2005 | EP1542687A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 06/22/2005 | EP1383752B1 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 06/22/2005 | EP1230231B1 Process for preparing n-(4-hydroxyphenyl)-n'-(4'-aminophenyl)-piperazine |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | CN1630648A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1207295C Method for preparing pyrazo-(4, 3-d) pyrimidine-7-ketone and its intermediate |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207268C Novel derivatives of 3-3-diphenylpropylamines |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6908999 Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908914 Antipsychotic cyclic N-aralkylamines |
| 06/21/2005 | US6908911 Antibacterial agents |
| 06/21/2005 | US6908493 1-(2,4-Diamino-phenoxy)-3-aminopropan-2-ol derivatives |
| 06/16/2005 | WO2005054408A1 Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate |
| 06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | WO2005030135A3 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/16/2005 | WO2005007076B1 Colchicine derivatives |
| 06/16/2005 | WO2004056750A8 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors |
| 06/16/2005 | US20050131118 Ionic liquids containing a sulfonate anion |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | US20050130966 Sodium channel modulators |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/15/2005 | EP1541566A1 Process for the separation of organic hydroxylamine and nitrosonium compounds and its use in the oxidation of hydroxy compounds |
| 06/15/2005 | EP1541565A1 Process for the separation of organic nitrosonium and/or hydroxylamine compounds by means of cation exchange resins and recovery and oxidation processes based thereon |
| 06/15/2005 | EP1540037A1 Organic salts and their use as reagents in electrochemical reactions |
| 06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/15/2005 | EP1539725A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |